Thiopurines in inflammatory bowel disease: New strategies for optimization of pharmacotherapy?

被引：7
|
作者：
Luc J. J. Derijks
Daniel W. Hommes
机构：
[1] Máxima Medical Center,Department of Clinical Pharmacy
来源：
Current Gastroenterology Reports | 2006年 / 8卷 / 2期
关键词：
Therapeutic Drug Monitoring; Thiopurine; Nodular Regenerative Hyperplasia; Thiopurine Therapy; TPMT Genotyping;
D O I：
10.1007/s11894-006-0001-0
中图分类号：
学科分类号：
摘要：
New strategies for optimizing thiopurine therapy of IBD are promising. TDM and TPMT genotyping seem to be important tools for fine tuning thiopurine therapy, thereby reducing toxicity and improving efficacy. ITPA genotyping and the use of 6-TG in IBD need further research before they can be advocated or banned.
引用
收藏
页码：89 / 92
页数：3
相关论文
共 50 条
  • [41] Tolerability profile of thiopurines in inflammatory bowel disease: a prospective experience
    Macaluso, Fabio Salvatore
    Renna, Sara
    Maida, Marcello
    Dimarco, Mariangela
    Sapienza, Chiara
    Affronti, Marco
    Orlando, Emanuele
    Rizzuto, Giulia
    Orlando, Rosalba
    Ventimiglia, Marco
    Cottone, Mario
    Orlando, Ambrogio
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2017, 52 (09) : 981 - 987
  • [42] Predictors of Therapeutic Remission to Thiopurines in Pediatric Inflammatory Bowel Disease
    Choi, Jennifer M.
    McGovern, Dermot P.
    Lee, Edward S.
    Berel, Dror
    Kwon, Soonil
    Landers, Carol J.
    Haritunians, Talin
    Targan, Stephan R.
    Rotter, Jerome I.
    Taylor, Kent D.
    Dubinsky, Marla
    GASTROENTEROLOGY, 2011, 140 (05) : S154 - S154
  • [43] The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy
    Hutson, J. R.
    Matlow, J. N.
    Moretti, M. E.
    Koren, G.
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2013, 33 (01) : 1 - 8
  • [44] The Pharmacotherapy of Inflammatory Bowel Disease in Child and Adolescence
    Kim, Kyung Mo
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2010, 53 (06): : 524 - 530
  • [45] PHARMACOTHERAPY OF CHRONIC INFLAMMATORY BOWEL-DISEASE
    MODIGLIANI, R
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1988, 118 (20) : 737 - 737
  • [46] New therapeutic strategies for treatment of inflammatory bowel disease
    Atreya, R.
    Neurath, M. F.
    MUCOSAL IMMUNOLOGY, 2008, 1 (03) : 175 - 182
  • [47] New strategies in the management of inflammatory bowel disease.
    Rutgeerts, P
    Baert, F
    ACTA CLINICA BELGICA, 1999, 54 (05): : 274 - 280
  • [48] Targets for new immunomodulation strategies in inflammatory bowel disease
    Monteleone, Giovanni
    Caruso, Roberta
    Pallone, Francesco
    AUTOIMMUNITY REVIEWS, 2014, 13 (01) : 11 - 14
  • [49] Thiopurines Prevent Advanced Colorectal Neoplasia in Patients With Inflammatory Bowel Disease
    van Schaik, Fiona D.
    Smeets, Hugo M.
    van der Heijden, Geert J.
    Siersema, Peter D.
    van Oijen, Martijn G.
    Oldenburg, Bas
    GASTROENTEROLOGY, 2011, 140 (05) : S42 - S43
  • [50] Editorial: weighing the global risk of cancer with thiopurines in inflammatory bowel disease
    Laharie, D.
    Riviere, P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 47 (05) : 689 - 690
12345